Hypoxaemia during sedated gastrointestinal endoscopy exceeds 40 % in morbidly obese (BMI ≥ 35 kg m-²) patients. High-flow nasal cannula alone often fails because of persistent airway collapse. A recent innovation in this domain is the COMBO Endoscopy Oropharyngeal Airway-a multifaceted device that encompasses capnography monitoring, bite block , oxygenation support, and oropharyngeal airway management.The purpose of this study is to investigate whether the combination of the COMBO Endoscopy Oropharyngeal Airway and High-Flow Nasal Cannula oxygenation reduces the incidence of hypoxemia in this population.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
410
Using the COMBO endoscopy oropharyngeal airway with High-Flow Nasal Cannula Oxygenation in sedated gastrointestinal endoscopy for morbidly obese patients
In this group, patients use high-flow nasal cannula oxygenation
Peking University First Hospital
Beijing, Beijing Municipality, China
RECRUITINGJinjiang Municipal Hospital
Jinjiang, Fujian, China
RECRUITINGThe First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
RECRUITINGThe Fifth Affiliated Hospital of Wenzhou Medical University
Lishui, Zhejiang, China
RECRUITINGTaizhou Hospital of Zhejiang Province
Taizhou, Zhejiang, China
RECRUITINGThe incidence of hypoxemia
75% ≤ SpO2 \< 90% for \<60 s
Time frame: Patients will be followed for the duration of hospital stay, an expected average about 2 hours
The incidence of sub-clinical respiratory depression
90% ≤ SpO2 \< 95%
Time frame: Patients will be followed for the duration of hospital stay, an expected average about 2 hours
The incidence of severe hypoxaemia
SpO2 \< 75% or 75% ≤ SpO2 \< 90% for ≥60 s
Time frame: Patients will be followed for the duration of hospital stay, an expected average about 2 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.